Market Indices
Sector Heatmap
MRNA — Moderna, Inc. Common Stock
NasdaqModerna, Inc. Common Stock
- O
- 202.09
- H
- 212.22
- L
- 186.64
- V
- 18.66M
MRNA — Latest News & Headlines
20 StoriesMRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum - Yahoo Finance
MRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum Yahoo Finance
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns - Stocktwits
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns Stocktwits
Moderna (MRNA) COO Juan Andres reports direct ownership of 125,000 common shares. - Stock Titan
Moderna (MRNA) COO Juan Andres reports direct ownership of 125,000 common shares. Stock Titan
Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know - TradingKey
Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know TradingKey
SA Asks: Is Moderna's stock now a sell after the recent run-up? - TradingView
SA Asks: Is Moderna's stock now a sell after the recent run-up? TradingView
Moderna (MRNA) Shares Surge on Cancer Vaccine Optimism Despite C - GuruFocus
Moderna (MRNA) Shares Surge on Cancer Vaccine Optimism Despite C GuruFocus
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds - The Globe and Mail
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds The Globe and Mail
Moderna (NasdaqGS:MRNA) Stock Forecast & Analyst Predictions - Simply Wall Street
Moderna (NasdaqGS:MRNA) Stock Forecast & Analyst Predictions Simply Wall Street
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains - MarketWatch
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains MarketWatch
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? - Zacks Investment Research
Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? Zacks Investment Research
Prediction: Moderna Stock Will Soar 100% by 2030 - Yahoo Finance
Prediction: Moderna Stock Will Soar 100% by 2030 Yahoo Finance
MRNA Stock Surges As FDA Releases Positive Briefing Documents Ahead Of Key Vaccine Meeting - Stocktwits
MRNA Stock Surges As FDA Releases Positive Briefing Documents Ahead Of Key Vaccine Meeting Stocktwits
Moderna (MRNA) Stock Looks Too Expensive For Its Sales Story - Simply Wall Street
Moderna (MRNA) Stock Looks Too Expensive For Its Sales Story Simply Wall Street
From $63 To $195: Moderna’s Two-Month Rerating Isn’t Done - Yahoo Finance
From $63 To $195: Moderna’s Two-Month Rerating Isn’t Done Yahoo Finance
Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running? - Yahoo Finance
Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running? Yahoo Finance
Moderna (MRNA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Moderna (MRNA) Stock Dips While Market Gains: Key Facts Yahoo Finance
Why Moderna (MRNA) Shares Are Falling Today - Yahoo Finance
Why Moderna (MRNA) Shares Are Falling Today Yahoo Finance
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips - Yahoo Finance
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips Yahoo Finance
Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak - Yahoo Finance
Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak Yahoo Finance
Novavax, Moderna stocks fall after WHO calls plague risk 'low' - Yahoo Finance
Novavax, Moderna stocks fall after WHO calls plague risk 'low' Yahoo Finance